171 related articles for article (PubMed ID: 34409757)
1. Interplay of Halogen and Hydrogen Bonding through Co-Crystallization in Pharmacologically Active Dihydropyrimidines: Insights from Crystal Structure and Energy Framework.
Bairagi KM; Ingle KS; Bhowal R; Mohurle SA; Hasija A; Alwassil OI; Venugopala KN; Chopra D; Nayak SK
Chempluschem; 2021 Aug; 86(8):1167-1176. PubMed ID: 34409757
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Halogen Substituents on the Synthesis and Structure of Co-Crystals of Pyridine Amides.
Abeysekera AM; Sinha AS; Aakeroy CB
Molecules; 2021 Feb; 26(4):. PubMed ID: 33669971
[TBL] [Abstract][Full Text] [Related]
3. Halogen- and hydrogen-bonded salts and co-crystals formed from 4-halo-2,3,5,6-tetrafluorophenol and cyclic secondary and tertiary amines: orthogonal and non-orthogonal halogen and hydrogen bonding, and synthetic analogues of halogen-bonded biological systems.
Takemura A; McAllister LJ; Hart S; Pridmore NE; Karadakov PB; Whitwood AC; Bruce DW
Chemistry; 2014 May; 20(22):6721-32. PubMed ID: 24796890
[TBL] [Abstract][Full Text] [Related]
4. A Combined Experimental and Computational Study of Halogen and Hydrogen Bonding in Molecular Salts of 5-Bromocytosine.
Aschi M; Toto Brocchi G; Portalone G
Molecules; 2021 May; 26(11):. PubMed ID: 34070959
[TBL] [Abstract][Full Text] [Related]
5. Halogen bonding and pharmaceutical cocrystals: the case of a widely used preservative.
Baldrighi M; Cavallo G; Chierotti MR; Gobetto R; Metrangolo P; Pilati T; Resnati G; Terraneo G
Mol Pharm; 2013 May; 10(5):1760-72. PubMed ID: 23514087
[TBL] [Abstract][Full Text] [Related]
6. Experimental investigation of halogen-bond hard-soft acid-base complementarity.
Riel AM; Jessop MJ; Decato DA; Massena CJ; Nascimento VR; Berryman OB
Acta Crystallogr B Struct Sci Cryst Eng Mater; 2017 Apr; 73(Pt 2):203-209. PubMed ID: 28362283
[TBL] [Abstract][Full Text] [Related]
7. Establishing Halogen-Bond Preferences in Molecules with Multiple Acceptor Sites.
Abeysekera AM; Averkiev BB; Sinha AS; Le Magueres P; Aakeröy CB
Chempluschem; 2021 May; 86(8):1049-1057. PubMed ID: 34008343
[TBL] [Abstract][Full Text] [Related]
8. Tuning solubility and stability of hydrochlorothiazide co-crystals.
Sanphui P; Rajput L
Acta Crystallogr B Struct Sci Cryst Eng Mater; 2014 Feb; 70(Pt 1):81-90. PubMed ID: 24441131
[TBL] [Abstract][Full Text] [Related]
9. Preparation of Progesterone Co-Crystals Based on Crystal Engineering Strategies.
Zeng H; Xiong J; Zhao Z; Qiao J; Xu D; Miao M; He L; Wu X
Molecules; 2019 Oct; 24(21):. PubMed ID: 31683599
[TBL] [Abstract][Full Text] [Related]
10. Orthogonal hydrogen/halogen bonding in 1-(2-methoxyphenyl)-1H-imidazole-2(3H)-thione-I2 adduct: an experimental and theoretical study.
El-Sheshtawy HS; Ibrahim MM; El-Mehasseb I; El-Kemary M
Spectrochim Acta A Mol Biomol Spectrosc; 2015 May; 143():120-7. PubMed ID: 25725208
[TBL] [Abstract][Full Text] [Related]
11. Hydrogen Bond Enhanced Halogen Bonds: A Synergistic Interaction in Chemistry and Biochemistry.
Riel AMS; Rowe RK; Ho EN; Carlsson AC; Rappé AK; Berryman OB; Ho PS
Acc Chem Res; 2019 Oct; 52(10):2870-2880. PubMed ID: 31318520
[TBL] [Abstract][Full Text] [Related]
12. Uracil Derivatives for Halogen-Bonded Cocrystals.
Benito M; Roselló Y; Barceló-Oliver M; Frontera A; Molins E
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639004
[TBL] [Abstract][Full Text] [Related]
13. Application of Halogen Bonding to Organocatalysis: A Theoretical Perspective.
Yang H; Wong MW
Molecules; 2020 Feb; 25(5):. PubMed ID: 32110944
[TBL] [Abstract][Full Text] [Related]
14. Co-crystals of caffeine and hydroxy-2-naphthoic acids: unusual formation of the carboxylic acid dimer in the presence of a heterosynthon.
Bucar DK; Henry RF; Lou X; Duerst RW; Borchardt TB; MacGillivray LR; Zhang GG
Mol Pharm; 2007; 4(3):339-46. PubMed ID: 17489605
[TBL] [Abstract][Full Text] [Related]
15. Structural Characterization of Co-Crystals of Chlordiazepoxide with
Garbacz P; Paukszta D; Sikorski A; Wesolowski M
Pharmaceutics; 2020 Jul; 12(7):. PubMed ID: 32659986
[TBL] [Abstract][Full Text] [Related]
16. Binary co-crystals of the active pharmaceutical ingredient 1,4-bis(4-pyridyl)-2,3-diaza-1,3-butadiene and camphoric acid.
Bisht KK; Patel P; Rachuri Y; Eringathodi S
Acta Crystallogr B Struct Sci Cryst Eng Mater; 2014 Feb; 70(Pt 1):63-71. PubMed ID: 24441129
[TBL] [Abstract][Full Text] [Related]
17. Competition between chalcogen and halogen bonding assessed through isostructural species.
De Silva V; Magueres PL; Averkiev BB; Aakeröy CB
Acta Crystallogr C Struct Chem; 2022 Dec; 78(Pt 12):716-721. PubMed ID: 36468554
[TBL] [Abstract][Full Text] [Related]
18. Structure-Energy Relationships of Halogen Bonds in Proteins.
Scholfield MR; Ford MC; Carlsson AC; Butta H; Mehl RA; Ho PS
Biochemistry; 2017 Jun; 56(22):2794-2802. PubMed ID: 28345933
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization, and molecular modeling of a pharmaceutical co-crystal: (2-chloro-4-nitrobenzoic acid):(nicotinamide).
Lemmerer A; Esterhuysen C; Bernstein J
J Pharm Sci; 2010 Sep; 99(9):4054-71. PubMed ID: 20574994
[TBL] [Abstract][Full Text] [Related]
20. In situ high-pressure crystallization and compression of halogen contacts in dichloromethane.
Podsiadło M; Dziubek K; Katrusiak A
Acta Crystallogr B; 2005 Oct; 61(Pt 5):595-600. PubMed ID: 16186660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
